Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction (NCT01208974) | Clinical Trial Compass
Active ā Not RecruitingNot Applicable
Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
United States21 participantsStarted 2010-03-16
Plain-language summary
The purpose of this research study is to see if a participant's nipple and areola can be safely preserved by adding radiation to these areas after a nipple-sparing mastectomy and immediate breast reconstruction.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients must have histologically confirmed in-situ or invasive breast carcinoma.
* Tis, T1, T2 invasive or non-invasive carcinoma of the breast; lesion less than 4 cm.
* Unifocal, multifocal or multicentric breast cancers that can be removed by nipple sparing mastectomy with negative surgical margins.
* No extensive intraductal component or patient with distant metastases.
* Patients must be \> 18 years of age.
* No concomitant or history of nipple discharge or skin involvement.
* No prior history of malignancy (less than 5 years prior to study entry), except non-melanomatous skin cancer.
* No prior history of radiation to the chest.
* No collagenous disease (systemic lupus erythematosis, scleroderma, dermatomyositis)No previous non-hormonal therapy including radiation or chemotherapy for current breast cancer.
* No patients with Paget's disease of the nipple.
* No patients with co-existing medical conditions with life expectancy \< 2 years.
* No pregnant or lactating women.
* Eastern Cooperative Oncology Group (ECOG) 0 - 2.
* Signed study-specific informed consent form prior to the study entry.
Exclusion Criteria:
* Retroareolar breast cancer lesions within one cm, depth from the skin surface.
* Concomitant or history of nipple discharge or skin involvement.
* Patient with distant metastases.
* Patient with extensive intraductal carcinoma.
* Any previously irradiated ipsilateral breast cancer.
* Patients with Paget's disease of the nipple.
* Patientā¦
What they're measuring
1
Maximum Tolerated Dose (MTD) of Prophylactic NAC Irradiation.